| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 434 | 7.720 | 6.322 | 6.726 | 763 | 1.035 | 1.941 | 2.416 |
| Total Income - EUR | - | - | 434 | 7.720 | 6.322 | 6.726 | 763 | 2.351 | 2.396 | 2.605 |
| Total Expenses - EUR | - | - | 148 | 631 | 1.748 | 2.406 | 1.198 | 1.963 | 2.085 | 4.867 |
| Gross Profit/Loss - EUR | - | - | 287 | 7.089 | 4.574 | 4.320 | -434 | 388 | 312 | -2.262 |
| Net Profit/Loss - EUR | - | - | 274 | 6.858 | 4.384 | 4.139 | -457 | 357 | 269 | -2.262 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Orl Medical Resolve Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 29 | 0 | 0 | 0 | 0 | 646 | 209 | 0 |
| Current Assets | - | - | 301 | 7.218 | 11.462 | 4.204 | 3.639 | 681 | 1.172 | 777 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 233 | 734 | 0 |
| Cash | - | - | 301 | 7.218 | 11.462 | 4.204 | 3.639 | 448 | 438 | 777 |
| Shareholders Funds | - | - | 317 | 7.169 | 11.415 | 4.188 | 3.639 | 406 | 674 | -1.592 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 13 | 48 | 47 | 16 | 1 | 359 | 518 | 2.369 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 647 | 190 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Orl Medical Resolve Srl